Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation

1 Dec 2016

Abstract excerpt

α-synuclein (aSyn) is associated with both sporadic and familial forms of Parkinson's disease (PD), the second most common neurodegenerative disorder after Alzheimer's disease. In particular, multiplications and point mutations in the gene encoding for aSyn cause familial forms of PD. Moreover, the accumulation of aSyn in Lewy Bodies and Lewy neurites in disorders such as PD, dementia with Lewy bodies, or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Neurological disorders and treatments
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27938414
DOI: 10.1186/s40478-016-0402-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregationPMID 27938414Read ↗

The A53E α-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture.Semantic proximity Read ↗

Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in NeurodegenerationSemantic proximity Read ↗

Comparison of Kinetics, Toxicity, Oligomer Formation, and Membrane Binding Capacity of α-Synuclein Familial Mutations at the A53 Site, Including the Newly Discovered A53V Mutation.Semantic proximity Read ↗

Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications.Semantic proximity Read ↗

Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models.Semantic proximity Read ↗

A novel alpha-synuclein K58N missense variant in a patient with Parkinson’s diseaseSemantic proximity Read ↗

Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synucleinSemantic proximity Read ↗

Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.Semantic proximity Read ↗

shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and ToxicitySemantic proximity Read ↗

The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.Semantic proximity Read ↗

The Familial α-Synuclein A53E Mutation Enhances Cell Death in Response to Environmental Toxins Due to a Larger Population of Oligomers.Semantic proximity Read ↗

α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic ChallengesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.